RansomHub ransomware group lists www.janvier-labs.com on its leak site
The RansomHub group has listed www.janvier-labs.com on its leak site, alleging a data breach.
- Published
- 2 min read
- 2 min read
- Ransomware group: RansomHub
- Country: France
- Sector: Healthcare
- Announcement date: March 20, 2025
The ransomware group known as RansomHub has officially listed the French organization Janvier Labs on its leak site. This announcement, posted on March 20, 2025, involves an allegation of a data breach targeting the company's infrastructure.
The claims made by RansomHub
According to the announcement made by the threat actor, an attack was carried out against Janvier Labs. The group claims that the operation was successful and that data was exfiltrated from the organization's systems. While the group claims the attack occurred around March 10, 2025, the public listing of the victim was made several days later.
Ransomware leak sites are frequently used by cybercriminal groups as a tool for double extortion. In these scenarios, attackers not only encrypt an organization's internal systems to disrupt operations but also steal sensitive information. The threat of releasing this stolen data on a public forum is used to pressure the victim into paying a ransom. The publication of such a listing indicates that the organization's data may be made public by the threat actors.
Details regarding the alleged stolen data
At this stage, the listing provides very little specific information regarding the content of the breach. There is no information regarding the nature of the leaked or threatened data, and no screenshots have been provided to substantiate the claims. Furthermore, the group has not specified the total size of the data or the total number of files involved in the incident.
- No specific data types have been named in the listing.
About Janvier Labs
Janvier Labs is a French company that specializes in the breeding and supply of laboratory animals for biomedical research. The organization provides high-quality animal models and various related services to research institutions and the pharmaceutical industry. Due to its role in the biomedical supply chain, the company operates within the sensitive healthcare sector.
Risk assessment and industry implications
The situation involving Janvier Labs may pose a significant risk of exposing sensitive data within the organization. Because the entity operates in the healthcare sector, a potential breach could lead to data protection violations under the General Data Protection Regulation (GDPR). If sensitive information is indeed compromised, there is a possibility that affected individuals could be exposed to identity theft or targeted phishing attacks.
The threat landscape regarding RansomHub is complex. Public information regarding the group is limited, and although it has been reported that the group's activities ceased in early 2025, such listings may be a reflection of past attacks. This highlights the importance of continuous monitoring, as threat actors may resurface or use old data for new extortion attempts.
For organizations in the healthcare and research sectors, such incidents can create secondary risks for supply chain partners. When a key supplier is compromised, the integrity of the entire research and pharmaceutical network may be called into question. To mitigate these risks, organizations typically implement defensive measures such as robust encryption, multi-factor authentication, and strict access controls. Regular security audits and comprehensive incident response plans are also essential for managing the potential fallout of a data exfiltration event.